Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

239 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Effects of Levodopa-Carbidopa Intestinal Gel on Dyskinesia and Non-Motor Symptoms Including Sleep: Results from a Meta-Analysis with 24-Month Follow-Up.
Chaudhuri KR, Antonini A, Pahwa R, Odin P, Titova N, Thakkar S, Snedecor SJ, Hegde S, Alobaidi A, Parra JC, Zadikoff C, Bergmann L, Standaert DG. Chaudhuri KR, et al. Among authors: odin p. J Parkinsons Dis. 2022;12(7):2071-2083. doi: 10.3233/JPD-223295. J Parkinsons Dis. 2022. PMID: 35964203 Free PMC article. Review.
International multicenter pilot study of the first comprehensive self-completed nonmotor symptoms questionnaire for Parkinson's disease: the NMSQuest study.
Chaudhuri KR, Martinez-Martin P, Schapira AH, Stocchi F, Sethi K, Odin P, Brown RG, Koller W, Barone P, MacPhee G, Kelly L, Rabey M, MacMahon D, Thomas S, Ondo W, Rye D, Forbes A, Tluk S, Dhawan V, Bowron A, Williams AJ, Olanow CW. Chaudhuri KR, et al. Among authors: odin p. Mov Disord. 2006 Jul;21(7):916-23. doi: 10.1002/mds.20844. Mov Disord. 2006. PMID: 16547944
The metric properties of a novel non-motor symptoms scale for Parkinson's disease: Results from an international pilot study.
Chaudhuri KR, Martinez-Martin P, Brown RG, Sethi K, Stocchi F, Odin P, Ondo W, Abe K, Macphee G, Macmahon D, Barone P, Rabey M, Forbes A, Breen K, Tluk S, Naidu Y, Olanow W, Williams AJ, Thomas S, Rye D, Tsuboi Y, Hand A, Schapira AH. Chaudhuri KR, et al. Among authors: odin p. Mov Disord. 2007 Oct 15;22(13):1901-11. doi: 10.1002/mds.21596. Mov Disord. 2007. PMID: 17674410
Clinical risk-benefit assessment of dopamine agonists.
Möller JC, Eggert KM, Unger M, Odin P, Chaudhuri KR, Oertel WH. Möller JC, et al. Among authors: odin p. Eur J Neurol. 2008 Sep;15 Suppl 2:15-23. doi: 10.1111/j.1468-1331.2008.02214.x. Eur J Neurol. 2008. PMID: 18702738 Review.
239 results